Vanguard Group Inc. Has $533.02 Million Position in Plexus Corp. $PLXS

Vanguard Group Inc. grew its holdings in Plexus Corp. (NASDAQ:PLXS) by 0.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,683,845 shares of the technology company’s stock after purchasing an additional 22,374 shares during the quarter. Vanguard Group Inc. owned about 13.65% of Plexus worth $533,016,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently modified their holdings of the stock. State Street Corp raised its holdings in Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock worth $143,361,000 after buying an additional 24,115 shares during the last quarter. American Century Companies Inc. raised its stake in shares of Plexus by 12.9% during the 2nd quarter. American Century Companies Inc. now owns 765,773 shares of the technology company’s stock worth $103,617,000 after purchasing an additional 87,551 shares during the period. Thrivent Financial for Lutherans boosted its stake in Plexus by 6.9% in the third quarter. Thrivent Financial for Lutherans now owns 298,117 shares of the technology company’s stock valued at $43,134,000 after acquiring an additional 19,248 shares during the last quarter. Qube Research & Technologies Ltd increased its position in Plexus by 37.1% in the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock worth $32,843,000 after buying an additional 65,644 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in Plexus by 1.8% during the second quarter. Bank of New York Mellon Corp now owns 240,635 shares of the technology company’s stock valued at $32,560,000 after purchasing an additional 4,339 shares during the last quarter. Institutional investors own 94.45% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Weiss Ratings cut shares of Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday. Williams Trading set a $195.00 price objective on shares of Plexus in a research report on Wednesday, January 28th. Benchmark increased their price objective on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. Finally, Needham & Company LLC upped their target price on Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a report on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Plexus has a consensus rating of “Moderate Buy” and a consensus target price of $189.20.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $203.99 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. Plexus Corp. has a one year low of $103.43 and a one year high of $211.84. The firm has a market capitalization of $5.46 billion, a P/E ratio of 31.72 and a beta of 0.81. The company’s fifty day moving average is $177.23 and its two-hundred day moving average is $154.63.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. During the same period in the previous year, the firm posted $1.73 EPS. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Analysts forecast that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Insiders Place Their Bets

In other Plexus news, Chairman Dean A. Foate sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $204.89, for a total value of $1,024,450.00. Following the transaction, the chairman directly owned 15,000 shares of the company’s stock, valued at $3,073,350. This represents a 25.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 8,120 shares of the company’s stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $205.65, for a total value of $1,669,878.00. Following the sale, the chief executive officer directly owned 78,598 shares in the company, valued at approximately $16,163,678.70. This represents a 9.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 47,995 shares of company stock valued at $9,692,416. Corporate insiders own 1.78% of the company’s stock.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.